TransAlta (NYSE:TAC) Azioni

TransAlta

TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.

WIIM

TransAlta shares are trading higher after Jefferies upgraded the stock from hold to buy.

U.S. stocks were higher, with the Dow Jones index gaining around 0.1% on Thursday.
Shares of CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) rose sharply during Thursday's session after BioNTech announced it will acquire the company in an <a href="https://www.benzinga.com/quote/CVAC">all-stock transaction</a>.
CureVac shares jumped 38% to $5.61 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>TELUS International (Cda) Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NASDAQ">TIXT</a>) gained 20.6% to $3.57 after the company announced it proposed the acquisition of TELUS Digital to accelerate AI and SaaS transformation across core business sectors.</li>
<li>Fortrea Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) jumped 15% to $6.25. Fortrea adopted limited-duration stockholder rights plan.</li>
<li>Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) gained 13.7% to $200.65 after the company reported better-than-expected quarterly financial results and issued upbeat outlook commentary.</li>
<li>Hippo Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) rose 13.1% to $30.64. The Baldwin Group entered into agreement to acquire Homebuilder Distribution Network from Hippo.</li>
<li>USA Rare Earth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) climbed 12.8% to $14.05.</li>
<li>DeFi Development Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFDV#NASDAQ">DFDV</a>) gained 11.7% to $29.34. The company announced it secured a $5 billion equity facility with RK Capital.</li>
<li>Yuanbao Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YB#NASDAQ">YB</a>) rose 11.7% to $17.58.</li>
<li>TransAlta Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) gained 7.4% to $11.25. Jefferies analyst Julien Dumoulin-Smith upgraded TransAlta from Hold to Buy and raised the price target from C$12 to C$20.</li>
<li>Genius Sports Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) rose 6.5% to $10.28. Texas Capital Securities analyst David Bain initiated coverage on Genius Sports with a Buy rating and announced a price target of $14.</li>
<li>BeOne Medicines Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) rose 6% to $277.93 after the company announced that the FDA approved a new tablet formulation of BRUKINSA for all five approved indications.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

News

Markets

Movers

Trading Ideas

CVAC

DFDV

FTRE

GENI

HIPO

ORCL

TIXT

USAR

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday

Jefferies analyst Julien Dumoulin-Smith upgrades TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) from Hold to Buy and raises the price target from C$12 to C$20.

Upgrades

Price Target

Analyst Ratings

TSX:TA

Jefferies Upgrades TransAlta to Buy, Raises Price Target to C$20

TransAlta Corporation ("TransAlta" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) announced today that the Toronto Stock Exchange ("TSX") has accepted the notice filed by the Company to implement a normal course issuer bid ("NCIB") for a portion of its common shares ("Common Shares").
Pursuant to the NCIB, TransAlta may repurchase up to a maximum of 14,000,000 Common Shares, representing approximately 4.7% of the 296,449,829 Common Shares issued and outstanding as at May 20, 2025. Purchases under the NCIB may be made through open market transactions on the TSX and any alternative Canadian trading systems on which the Common Shares are traded, based on the prevailing market price. Any Common Shares purchased under the NCIB will be cancelled.

Buybacks

TransAlta Announces TSX Approval For Normal Course Issuer Bid To Repurchase Up To 14M Common Shares, Representing 4.7% Of Outstanding Shares, With All Repurchased Shares To Be Cancelled

RBC Capital analyst Maurice Choy maintains TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) with a Outperform and lowers the price target from $23 to $20.

RBC Capital Maintains Outperform on TransAlta, Lowers Price Target to $20

TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) reported quarterly earnings of $0.07 per share. This is a 76.67 percent decrease over earnings of $0.30 per share from the same period last year. The company reported $528.04 million in sales this quarter. This is a 24.85 percent decrease over sales of $702.61 million the same period last year.

Earnings

TransAlta Q1 Adj. EPS $0.07 Down From $0.30 YoY, Sales $528.04M Down From $702.61M YoY

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 150 points on Thursday.
Shares of Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/news/earnings/25/04/44853254/alcoa-shares-gain-after-mixed-q1-results-eps-beat-revenues-miss">first-quarter results</a>.
Alcoa reported quarterly earnings of $2.15 per share, which beat the analyst consensus estimate of $1.70. Quarterly revenue came in at $3.37 billion, which missed the analyst consensus estimate of $3.53 billion and is an increase over revenue of $2.6 billion from the same period last year.
Alcoa shares dipped 2.6% to $24.43 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Sionna Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SION#NASDAQ">SION</a>) shares tumbled 30% to $7.00 in pre-market trading following a 5% gain on Wednesday.</li>
<li>Mercer International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>) shares dipped 20.4% to $4.10 in pre-market trading. Mercer International will release its first quarter results for the period ending March 31, 2025 on Thursday, May 1, after the closing bell.</li>
<li>InnovAge Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) fell 15.5% to $2.40 in pre-market trading.</li>
<li>Torrid Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) fell 14.4% to $5.01 in pre-market trading after gaining around 6% on Wednesday.</li>
<li>Liberty Latin America Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILAK#NASDAQ">LILAK</a>) dipped 11.4% to $4.61 in pre-market trading.</li>
<li>Interface, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) shares fell 8.7% to $17.01 in pre-market trading.</li>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) fell 7.4% to $13.20 in pre-market trading as the company announced the pricing of common stock offering.</li>
<li>TransAlta Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) fell 6.3% to $8.12 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44836659/top-3-industrials-stocks-that-may-plunge-this-month">Top 3 Industrials Stocks That May Plunge This Month</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

CURV

INNV

LILAK

MERC

SION

TILE

Alcoa Posts Weak Revenue, Joins QXO And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

The ASPP will terminate on the earliest of the date on which: (a) the maximum purchase limits under the ASPP are reached; (b) May 8, 2025; or (c) the Company terminates the ASPP in accordance with its terms. &nbsp;

TransAlta Enters Automatic Share Purchase Plan

CBRE

EQIX

WELL

WHLR

Shares of REIT and utility stocks are trading lower amid overall market weakness. Rising Treasury yields may be driving a rotation out of income-paying sectors.

TransAlta shares are trading higher after the company reported a year-over-year increase in Q4 sales results and announced an 8% increase in its dividend.

The company declared a dividend of C$0.065 per common share to be payable on July 1, 2025 to shareholders of record at the close of business on June 1, 2025.

Dividends

TransAlta Boosts Common Share Dividend By 8% From C$0.24 To C$0.26 Per Share On An Annualized Basis

TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $0.04 by 650 percent. This is a 10 percent decrease over losses of $(0.20) per share from the same period last year. The company reported $678.00 million in sales this quarter. This is a 47.88 percent increase over sales of $458.48 million the same period last year.

Earnings Misses

TransAlta Q4 2024 GAAP EPS C$(0.22) Misses C$0.04 Estimate, Sales C$678.00M Up From C$624M YoY

ACCO

AKAM

ALIT

ALRM

ARDX

ATHM

AXTI

BABA

BBDC

BBIO

BIGC

BILI

BIRK

BJRI

BKNG

BLDR

CARG

CCRD

CDRO

CELH

CERS

CGAU

COKE

COLD

CPRT

CRAI

CSTM

DAVA

DBRG

DGICA

DGICB

DINO

DVAX

EPAM

ESAB

EXPI

FIVN

FRPT

FYBR

GDYN

GKOS

GLOB

GLPI

GMED

GRAL

INDI

INDV

INOD

INSM

IRTC

ITGR

Earnings Scheduled For February 20, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies analyst David Katz upgraded the rating for Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) from Hold to Buy and raised the price target from $105 to $118. Wynn Resorts shares closed at $88.82 on Friday. <a href="https://www.benzinga.com/quote/wynn/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>CIBC analyst Mark Jarvi upgraded TransAlta Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) from Neutral to Outperformer and lowered the price target from C$23 to C$19.5. TransAlta shares closed at $10.53 on Friday. <a href="https://www.benzinga.com/quote/TAC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Matthew Boss upgraded the rating for Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Neutral to Overweight and boosted the price target from $41 to $47. Bath &amp; Body Works shares closed at $36.47 on Friday. <a href="https://www.benzinga.com/quote/BBWI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Maher Yaghi upgraded Digital Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) from Sector Perform to Sector Outperform and announced a $208 price target. Digital Realty Trust shares closed at $164.28 on Friday. <a href="https://www.benzinga.com/quote/DLR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst James Shin upgraded Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) from Hold to Buy and raised the price target from $80 to $120. Gilead shares closed at $104.08 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying BBWI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="503" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18065553/image-152-1024x503.png" alt="" class="wp-image-786637" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18065553/image-152-1024x503.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18065553/image-152-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18065553/image-152-768x377.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/18065553/image-152.png 1133w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43730195/top-3-defensive-stocks-that-may-collapse-in-q1">Top 3 Defensive Stocks That May Collapse In Q1</a></li>
</ul>

BBWI

CRSP

GILD

WYNN

This Bath & Body Works Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

CIBC analyst Mark Jarvi upgrades TransAlta (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAC#NYSE">TAC</a>) from Neutral to Outperformer and lowers the price target from C$23 to C$19.5.

CIBC Upgrades TransAlta to Outperformer, Lowers Price Target to C$19.5

Scotiabank analyst Robert Hope downgrades TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) from Sector Outperform to Sector Perform and raises the price target from C$19 to C$21.

Downgrades

Scotiabank Downgrades TransAlta to Sector Perform, Raises Price Target to C$21

TransAlta shares are trading higher. The stock may be moving higher amid a report Nvidia-backed Cohere is looking to open a multi-billion AI data center in Canada.

In order to meet the requirements of the federal Competition Bureau, TransAlta has also entered into a consent agreement with the Commissioner of Competition pursuant to which TransAlta has agreed to divest Heartland's Poplar Hill and Rainbow Lake assets following closing of the Transaction.&nbsp;

TransAlta Enters Amended Agreement To Acquire Heartland Generation From Energy Capital Partners At Reduced Price

RBC Capital analyst Maurice Choy maintains TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) with a Outperform and raises the price target from C$14 to C$16.

RBC Capital Maintains Outperform on TransAlta, Raises Price Target to C$16

Press Releases

TransAlta Declares Dividends

TransAlta to Host Fourth Quarter and Full Year 2024 Results Conference Call

TransAlta Reports Strong 2024 Results, Announces Dividend Increase and 2025 Annual Guidance

TransAlta Corporation Enters into Automatic Share Purchase Plan

TransAlta to Host Annual Meeting of Shareholders and First Quarter 2025 Results Conference Call

Management

TransAlta Corporation Announces Results of the 2025 Annual and Special Meeting of Shareholders and Election of all Directors

Comments

TransAlta

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO